Polling Shows Strong Bipartisan Support for Immediate Action on Biosimilars to Reduce Health Care Costs

A clear majority of voters across party lines favor immediate action to lower drug prices by acting to increase use of biosimilars, according to a new HarrisX poll. The findings underscore the need for policymakers to pursue commonsense policy reform that will reduce patients’ health costs and increase access to critical biosimilars therapies.